Nehlig A. The neuroprotective effects of cocoa flavanol and its influence on cognitive performance. Br J Clin Pharmacol. 2013 Mar; 75(3):716–27. doi:10.1111/j.1365–2125.2012.04378.x.
Nogueira L., et al . (-)-Epicatechin enhances fatigue resistance and oxidative capacity in mouse muscle. J Physiol. 2011 Sep 15; 589(Pt 18):4615–31. Epub 2011 Jul 25. doi:10.1113/ jphysiol.2011.209924.
Persson I. A., et al. Effects of cocoa extract and dark chocolate on angiotensin-converting enzyme and nitric oxide in human endothelial cells and healthy volunteers — a nutrigenomics perspective. J Cardiovasc Pharmacol. 2011 Jan; 57(1):44–50. doi:10.1097/FJC.0b013 e3181fe62e3.
Sathyapalan T., et al . High cocoa polyphenol rich chocolate may reduce the burden of the symptoms in chronic fatigue syndrome. Nutr J. 2010 Nov 22; 9:55. doi:10.1186/1475-2891-9-55.
Кофермент Q10
Cooper J. M., et al. Coenzyme Q10 and vitamin E deficiency in Friedreich’s ataxia: predictor of efifcacy of vitamin E and coenzyme Q10 therapy. Eur J Neurol. 2008 Dec; 15(12):1371–9. doi:10.1111/j.1468–1331.2008.02318.x.
Crane F. L., Low H., Sun I. L. Evidence for a relation between plasma membrane coenzyme Q and autism. Front Biosci (Elite Ed). 2013 Jun 1; 5:1011–6.
Del Pozo-Cruz J., et al. Relationship between functional capacity and body mass index with plasma coenzyme Q10 and oxidative damage in community-dwelling elderly-people. Exp Gerontol. 2014 Apr; 52:46–54. Epub 2014 Feb 7.
Duberley K. E., et al. Effect of coenzyme Q10 supplementation on mitochondrial electron transport chain activity and mitochondrial oxidative stress in coenzyme Q10 deficient human neuronal cells. Int J Biochem Cell Biol. 2014 May; 50:60–3. Epub 2014 Feb 15. doi:10.1016/j. biocel.2014.02.003.
Liang J. M., et al. Role of mitochondrial function in the protective effects of ischaemic postconditioning on ischaemia/reperfusion cerebral damage. J Int Med Res. 2013 Jun 1; 41(3):618–27. Epub 2013 Apr 4. doi:10.1177/0300060513476587.
Langsjoen P. H., Langsjoen A. M . Supplemental ubiquinol in patients with advanced congestive heart failure. Biofactors. 2008; 32(1–4):119–28. doi:10.1002/biof.5520320114.
Lass A., Sohal R. S. Comparisons of coenzyme Q bound to mitochondrial membrane proteins among different mammalian species. Free Radic Biol Med. 1999 Jul; 27(1–2):220–6. doi:10.1016/S0891-5849(99)00085-4.
Mancuso M., et al. Coenzyme Q10 in neuromuscular and neurodegenerative disorders. Curr Drug Targets. 2010 Jan; 11(1):111–21. doi:10.2174/1 38945010790031018.
Matthews R. T., et al. Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects. Proc Natl Acad Sci U S A. 1998 Jul 21; 95(15):8892–7.
Mortensen S. A., et al. Coenzyme Q10: clinical benefits with biochemical correlates suggesting a scientific breakthrough in the management of chronic heart failure. Int J Tissue React. 1990; 12(3):155–62.
Muroyama A. An alternative medical approach for the neuroprotective therapy to slow the progression of Parkinson’s disease. Yakugaku Zasshi. 2013; 133(8):849–56. doi:10.1248 /yakushi.13-00158.
Morris G., et al. Coenzyme Q10 depletion in medical and neuropsychiatric disorders: potential repercussions and therapeutic implications. Mol Neurobiol. 2013 Dec; 48(3):883–903. Epub 2013 Jun 13. doi:10.1007/ s12035-013-8477-8.
Nicolson G. L. Mitochondrial dysfunction and chronic disease: treatment with natural supplements. Altern Ther Health Med. 2013 Aug 15. pii: at5027. Epub ahead of print.
Ochoa J. J., et al. Coenzyme Q10 protects from aging-related oxidative stress and improves mitochondrial function in heart of rats fed a polyunsaturated fatty acid (PUFA)-rich diet. J Gerontol A Biol Sci Med Sci. 2005 Aug; 60(8):970–5. doi:10.1093/gerona/60.8.970.
Rodriguez M. C., et al. Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders. Muscle Nerve. 2007 Feb; 35(2):235–42. doi:10.1002/mus.20688.
Rosenfeldt F. L., et al. Coenzyme Q10 improves the tolerance of the senescent myocardium to aerobic and ischemic stress: studies in rats and in human atrial tissue. Biofactors. 1999; 9(2–4):291–9. doi:10.1002/ biof.5520090226.
Rosenfeldt F. L., et al. Coenzyme Q10 protects the aging heart against stress: studies in rats, human tissues, and patients. Ann NY Acad Sci. 2002 Apr; 959:355–9; discussion 463–5. doi:10.1111/j.1749–6632.2002. tb02106.x.
Rosenfeldt F. L., et al. The effects of ageing on the response to cardiac surgery: protective strategies for the ageing myocardium. Biogerontology. 2002;3(1–2):37–40.
Salama M., et al. Co-enzyme Q10 to treat neurological disorders: basic mechanisms, clinical outcomes, and future research direction. CNS Neurol Disord Drug Targets. 2013 Aug; 12(5):641–4. Epub 2013 Apr 4. doi:1 0.2174/18715273113129990071.
Shults C. W., et al. Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Arch Neurol. 2002 Oct; 59(10):1541–50. doi:10.1001/archneur.59.10.1541.
Sinatra S. T. The Sinatra solution: metabolic cardiology. Laguna Beach, CA: Basic Health Publications, Inc; 2011.
Sohal R. S., Forster M. J. Coenzyme Q, oxidative stress and aging. Mitochondrion. 2007 Jun; 7 Suppl:S103–11. doi:10.1016/j.mito.2007.03.006.
Spindler M., Beal M. F., Henchcliffe C. Coenzyme Q10 effects in neurodegenerative disease. Neuropsychiatr Dis Treat. 2009; 5:597–610. Epub 2009 Nov 16. doi:10.2147/NDT.S5212.
Совместное применение статинов и кофермента Q10
Brown M. S., inventor. Merck & Co., Inc., assignee. Coenzyme Q10 with HMG-CoA reductase inhibitors. United States patent US 4933165. 1989 Jan 18.
Caso G., et al. Effect of coenzyme Q10 on myopathic symptoms in patients treated with statins. Am J Cardiol. 2007 May 15; 99(10):1409–12. doi:10.1016/j.amjcard.2006.12.063.
Marcoff L., Thompson P. D. The role of coenzyme Q10 in statin-associated myopathy: a systematic review. J Am Coll Cardiol. 2007 Jun 12; 49(23):2231–7. doi:10.1016/j.jacc.2007.02.049.
Parker B. A., et al. Effect of statins on creatine kinase levels before and after a marathon run. Am J Cardiol. 2012 Jan 15; 109(2):282–7. doi:10.1016/j. amjcard.2011.08.045.
Tobert J. A., inventor. Merck & Co Inc., assignee. Coenzyme Q10 with HMG-CoA reductase inhibitors. United States patent US 4929437. 1990 May 29.
L-карнитин
Akisu M., et al. Protective effect of dietary supplementation with L-arginine and L-carnitine on hypoxia/reoxygenation-induced necrotizing enterocolitis in young mice. Bio Neonate. 2002;81(4):260–5. doi:10.1159/000056757. Bahl J. J., Bressler R. The pharmacology of carnitine. Annu Rev Pharmacol Toxicol. 1987;27: 257–77. doi:10.1146/annurev.pa.27.040187.001353.
Binienda Z. K. Neuroprotective effects of L-carnitine in induced mitochondrial dysfunction. Ann NY Acad Sci. 2003 May; 993:289–95; discussion 345–9. doi:10.1111/j.1749–6632.2003.tb07536.
Brass E. P., Hoppel C. L. Relationship between acid-soluble carnitine and coenzyme A pools in vivo. Biochem J. 1980 Sep 15; 190(3):495–504. doi:10.1042/bj1900495.
Bremer J. Carnitine: metabolism and functions. Physiol Rev. 1983 Oct; 63(4):1420–80.
Ferrari R., et al. Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review. Ann NY Acad Sci. 2004 Nov; 1033:79–91. doi:10.1196/annals.1320.007.
Читать дальше